DMAC

Dopo l'orario di chiusura: 4.19

Diamedica Therapeutics Inc (DMAC)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Diamedica Therapeutics Inc

(763) 496-5454

301 CARLSON PARKWAY, MINNEAPOLIS, MN

Prossima data di guadagno

Ultimi documenti SEC

DMAC's Discussions on Twitter

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-04-09	Iniziato	Oppenheimer	Outperform
2021-02-17	Iniziato	ROTH Capital	Buy
2020-10-30	Iniziato	Guggenheim	Buy
2020-07-08	Iniziato	Maxim Group	Buy
2019-04-30	Iniziato	Dougherty & Company	Buy
2019-03-05	Iniziato	Lake Street	Buy

Mostra tutto

Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

Diamedica Therapeutics Inc (DMAC)

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie

Point72 DIFC Ltd Acquires Shares of 2,848 Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Commonwealth Equity Services LLC Invests $303,000 in Diebold Nixdorf, Incorporated (NYSE:DBD) - Defense World

US FDA Closes Out Problem Applications One Federal Register Notice At A Time - Pink Sheet

Ameritas Investment Partners Inc. Has $1.82 Million Stake in Dolby Laboratories, Inc. (NYSE:DLB) - Defense World

Domino’s Pizza, Inc. (NYSE:DPZ) Position Lowered by Epoch Investment Partners Inc. - Defense World

Victory Capital Management Inc. Sells 10,924 Shares of Dolby Laboratories, Inc. (NYSE:DLB) - Defense World

Dolby Laboratories, Inc. (NYSE:DLB) Shares Sold by Federated Hermes Inc. - Defense World

Deftones’ Album Rises To A New Peak–Nearly 20 Years After Its Release - Forbes

Deutsche Telekom downgraded to Neutral from Outperform at Oddo BHF - TipRanks

Insiders See US$9.05m Investment In DiaMedica Therapeutics Jump Last Week - Simply Wall St

DiaMedica Therapeutics (NASDAQ:DMAC) Shares Up 2.7% - Defense World

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 2.7% - MarketBeat

DMAC stock touches 52-week high at $4.11 amid bullish trend - Investing.com

DMAC stock touches 52-week high at $4.11 amid bullish trend - Investing.com India

DMAC stock touches 52-week high at $4.11 amid bullish trend - Investing.com UK

DiaMedica Therapeutics Upcoming Conference Participation - Business Wire

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

DMAC stock touches 52-week high at $3.85 amid robust gains - Investing.com

DMAC stock touches 52-week high at $3.85 amid robust gains - Investing.com India

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Shares Purchased by Vanguard Group Inc. - Defense World

Vanguard Group Inc. Acquires 211,351 Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - MarketBeat

Oppenheimer Reiterates “Outperform” Rating for DiaMedica Therapeutics (NASDAQ:DMAC) - Defense World

DiaMedica Therapeutics' (DMAC) Outperform Rating Reaffirmed at Oppenheimer - MarketBeat

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Update - MarketBeat

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Down 17.0% in July - Defense World

Earnings call: DiaMedica Therapeutics highlights solid progress in Q2 - Investing.com

Earnings call: DiaMedica Therapeutics highlights solid progress in Q2 - Investing.com India

Earnings call: DiaMedica Therapeutics highlights solid progress in Q2 By Investing.com - Investing.com Canada

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2024 Earnings Call Transcript - Insider Monkey

DiaMedica Therapeutics Inc. (DMAC) Q2 2024 Earnings Call Transcript - Seeking Alpha

DiaMedica Therapeutics (NASDAQ:DMAC) Releases Earnings Results - MarketBeat

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results - Business Wire

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday - Defense World

DiaMedica Therapeutics (DMAC) Scheduled to Post Earnings on Wednesday - MarketBeat

Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year? - Yahoo Finance

DiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024 - Business Wire

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Up 10.8% in July - MarketBeat

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Grows By 10.8% - Defense World

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Up 22.1% in June - MarketBeat

Chronic Kidney Disease FDA Approvals, Emerging Drugs, - openPR

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) 12% gain last week benefited both retail investors who own 45% as well as insiders - Simply Wall St

DiaMedica: Early 2025 Interim Futility Analysis Could Be A Major Inflection Point - Seeking Alpha

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 50% ownership, insiders own 39% - Yahoo Finance

DiaMedica Therapeutics Releases Preeclampsia White Paper and Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia - Business Wire

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Major Shareholder Koch Thomas Von Acquires 1,200,000 Shares of Stock - Defense World

RA Capital Management buys $49.95m of Eliem Therapeutics stock By Investing.com - Investing.com Canada

Insider Buying: DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Major Shareholder Buys 1,200,000 Shares of Stock - MarketBeat

Swedish Match seeks FDA nod for wider snus marketing By Investing.com - Investing.com

DiaMedica Therapeutics insider buys $3m in company shares By Investing.com - Investing.com UK

DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement - Business Wire

Analyzing the Impact of Earnings Reports on DiaMedica Therapeutics Inc Inc. (DMAC) Price Performance - The InvestChronicle

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a DMAC